RJFSA
BNGO icon

Raymond James Financial Services Advisors’s Bionano Genomics BNGO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.88K Buy
326
+18
+6% +$560 ﹤0.01% 3427
2024
Q2 		$12.5K Hold
308
– – ﹤0.01% 3368
2024
Q1 		$20.5K Buy
+308
New +$23K ﹤0.01% 3343
2021
Q4 		– Sell
-25
Closed -$82K – 3327
2021
Q3 		$82K Sell
25
-31
-55% -$108K ﹤0.01% 3137
2021
Q2 		$248K Buy
56
+24
+75% +$94.8K ﹤0.01% 2849
2021
Q1 		$155K Buy
+32
New +$180K ﹤0.01% 2963

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Raymond James Financial Services Advisors's BNGO Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Bionano Genomics (BNGO) stake by 5.8% in Q3 2024, buying an estimated $560 and bringing the position to 326 shares worth $8.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

Raymond James Financial Services Advisors first reported a position in BNGO in Q1 2021 and has held it in 6 quarters since. The position peaked at $248K in Q2 2021. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Raymond James Financial Services Advisors held 326 shares of Bionano Genomics worth $8.88K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 18 Bionano Genomics shares in Q3 2024, an estimated $560.
  • Bionano Genomics made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3427 holding.
  • Raymond James Financial Services Advisors first reported a position in Bionano Genomics in Q1 2021 and has held it in 6 quarters since.
  • Raymond James Financial Services Advisors's Bionano Genomics position peaked at $248K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.